MAST vs FAST: Meta-Analysis of Diagnostic Scores for Fibrotic MASH

A 13.1 KB document by Shengfang Liu contains a meta-analysis comparing two non-invasive scores for diagnosing metabolic dysfunction-associated steatohepatitis with significant fibrosis. The analysis, registered in PROSPERO, included four studies and calculated pooled sensitivity, specificity, and AUC for the FibroScan-AST (FAST) and MRI-AST (MAST) scores. The author concluded that while MAST showed better sensitivity and stability, the overall diagnostic accuracy of the two scores did not differ statistically.

Use Cases

• Compare the diagnostic performance of FAST and MAST scores based on the reported sensitivity and specificity metrics.
• Assess the heterogeneity and threshold variability of diagnostic tests based on the meta-analysis results.
• Inform clinical decision-making for risk-stratified diagnostic pathways for fibrotic MASH based on the reported likelihood ratios and AUC values.

Strengths

• The analysis follows PRISMA guidelines and the protocol was registered in PROSPERO (CRD420251109029).
• Results include specific performance metrics with 95% confidence intervals, such as FAST AUC of 0.83 and MAST AUC of 0.84.
• The document is openly available under a CC-BY-4.0 license.

Limitations

• The core limitation noted by the author is that only four studies were included, restricting the reliability of the pooled estimates.
• The dataset is a 13.1 KB DOCX file, indicating a very limited scope focused on summary statistics rather than raw patient data.
• Column-level documentation is absent; field semantics must be inferred from the text after download.

Provenance

Source

Shengfang Liu via figshare.

Collection Method

Systematic review and meta-analysis of four studies comparing FAST and MAST scores to liver biopsy.

Freshness

Last updated 2026-04-21 04:20:10; freshness should be verified.